Literature DB >> 12746566

A comparative immunohistochemical study of spontaneous and chemically induced pheochromocytomas in B6C3F1 mice.

Georgette D Hill1, Virgilio Pace, Elke Persohn, Christina Bresser, Joseph K Haseman, Arthur S Tischler, Abraham Nyska.   

Abstract

Spontaneously occurring and chemically induced pheochromocytomas are rare in mice. That the mouse pheochromocytoma is a more appropriate animal model than that of the rat for study of human medullary adrenal tumors has been suggested. The expression of phenylethanolamine-N-methyltransferase (PNMT), the enzyme responsible for production of epinephrine from norepinephrine, is common to both mouse and human pheochromocytomas. This investigation assessed the expression of the immunohistochemical markers PNMT, tyrosine hydroxylase (TH), and chromogranin A (CGA) in spontaneously occurring and chemically induced pheochromocytomas in the B6C3F1 mouse. Spontaneous tumors were derived from control animals from 10 different studies and the pheochromocytomas from treated groups from 4 different studies. All tumors were positive for maximal TH expression. A highly significant difference in PNMT expression (p < 0.01) occurred between spontaneously occurring pheochromocytomas classified as benign or "malignant" by the criteria of toxicologic pathology. Chemically induced tumors showed intermediate PNMT staining. A marked reduction in CGA expression occurred in pheochromocytomas induced by technical grade pentachlorophenol, compared to the other three chemicals and the spontaneously occurring tumors. These findings suggest that immunohistochemistry is a reliable tool in investigating the functional capabilities of pheochromocytomas in mice. PNMT expression is a tightly regulated component of the chromaffin cell phenotype and appears to be readily lost in mouse pheochromocytomas, particularly those with aggressive characteristics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746566     DOI: 10.1385/ep:14:1:81

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  16 in total

1.  Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update.

Authors:  J K Haseman; J R Hailey; R W Morris
Journal:  Toxicol Pathol       Date:  1998 May-Jun       Impact factor: 1.902

2.  Role of glucocorticoids in expression of the adrenergic phenotype in rat embryonic adrenal gland.

Authors:  M C Bohn; M Goldstein; I B Black
Journal:  Dev Biol       Date:  1981-02       Impact factor: 3.582

3.  Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies.

Authors:  G M Portel-Gomes; L Grimelius; H Johansson; E Wilander; M Stridsberg
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

4.  Immunohistochemical and morphological characterization of spontaneously occurring pheochromocytomas in the aging mouse.

Authors:  A S Tischler; W Sheldon; R Gray
Journal:  Vet Pathol       Date:  1996-09       Impact factor: 2.221

5.  Protein A, avidin, and biotin in immunohistochemistry.

Authors:  S M Hsu; L Raine
Journal:  J Histochem Cytochem       Date:  1981-11       Impact factor: 2.479

6.  Vitamin D3-induced proliferative lesions in the rat adrenal medulla.

Authors:  A S Tischler; J F Powers; M Pignatello; P Tsokas; J C Downing; R M McClain
Journal:  Toxicol Sci       Date:  1999-09       Impact factor: 4.849

Review 7.  Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys.

Authors:  L S Gold; N B Manley; T H Slone; J M Ward
Journal:  Toxicol Pathol       Date:  2001 Nov-Dec       Impact factor: 1.902

8.  Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates.

Authors:  S J Diaz-Cano; M de Miguel; A Blanes; R Tashjian; H Galera; H J Wolfe
Journal:  J Pathol       Date:  2000-10       Impact factor: 7.996

9.  Lack of correlation between the capability of inducing sister-chromatid exchanges in vivo and carcinogenic potency, for 16 aromatic amines and azo derivatives.

Authors:  S Parodi; A Zunino; L Ottaggio; M De Ferrari; L Santi
Journal:  Mutat Res       Date:  1983-03       Impact factor: 2.433

10.  Tyrosine hydroxylase indicates cell differentiation of catecholamine biosynthesis in neuroendocrine tumors.

Authors:  K Iwase; A Nagasaka; I Nagatsu; K Kiuchi; T Nagatsu; H Funahashi; T Tsujimura; A Inagaki; A Nakai; T Kishikawa
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

View more
  4 in total

Review 1.  Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System.

Authors:  Annamaria Brändli-Baiocco; Emmanuelle Balme; Marc Bruder; Sundeep Chandra; Juergen Hellmann; Mark J Hoenerhoff; Takahito Kambara; Christian Landes; Barbara Lenz; Mark Mense; Susanne Rittinghausen; Hiroshi Satoh; Frédéric Schorsch; Frank Seeliger; Takuji Tanaka; Minoru Tsuchitani; Zbigniew Wojcinski; Thomas J Rosol
Journal:  J Toxicol Pathol       Date:  2018-07-28       Impact factor: 1.628

2.  Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center.

Authors:  Auryan Szalat; Merav Fraenkel; Victoria Doviner; Asher Salmon; David J Gross
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

3.  MicroCT for high-resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice.

Authors:  Shoichiro Ohta; Edwin W Lai; John C Morris; Douglas A Bakan; Brenda Klaunberg; Susannah Cleary; James F Powers; Arthur S Tischler; Mones Abu-Asab; Daniel Schimel; Karel Pacak
Journal:  Int J Cancer       Date:  2006-11-01       Impact factor: 7.396

4.  Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.

Authors:  Seung Eun Lee; Ensel Oh; Boram Lee; Yu Jin Kim; Doo-Yi Oh; Kyungsoo Jung; Jong-Sun Choi; Junghan Kim; Sung Joo Kim; Jung Wook Yang; Jungsuk An; Young Lyun Oh; Yoon La Choi
Journal:  Oncotarget       Date:  2016-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.